Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 min 47 sec ago

Elite Pharmaceuticals Announces Changes to their Board of Directors

Tue, 04/12/2016 - 12:53
Gene Pfeifer Joins Elite’s Board NORTHVALE, N.J., April 12, 2016 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) announced today that its Board of Directors has appointed Eugene P...
Biopharmaceuticals, Personnel
Elite Pharmaceuticals

Bioness(R) Releases The Second Gernation Of The Bioness Integrated Therapy System (BITS(R))

Mon, 04/11/2016 - 19:57
Company rebuilt the second generation platform from the ground up, integrating feedback from customers to develop new treatment therapy programs and outcome measures VALENCIA, Calif., April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Bioness ...
Devices, Product Launch
Bioness, Bioness Integrated Therapy System, rehabilitation, physical therapy

Beyhan Zaim appointed Vice President Commercial Development and Alzheimer's Disease Global Lead, Neurology Business Group at Eisai Inc.

Mon, 04/11/2016 - 19:51
WOODCLIFF LAKE, N.J., April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced the immediate appointment of Beyhan Zaim as Vice President Commercial Development & Alzhei...
Biopharmaceuticals, Neurology, Personnel
Eisai, Alzheimer's Disease

Adapt Pharma Names Mike Kelly President of U.S. Operations

Mon, 04/11/2016 - 19:48
Contributing Over 25 Years of Pharmaceutical Expertise to Adapt Executive Team DUBLIN, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Adapt Pharma, ( announced today that Mike Kelly has been appointed as President of U....
Biopharmaceuticals, Personnel
Adapt Pharma, NARCAN, naloxone

Stryker Acquires SafeWire Product Portfolio for Use in Minimally-Invasive (MIS) Spine Procedures

Mon, 04/11/2016 - 19:46
Technology Used with Stryker’s Percutaneous ES2 Spinal Fixation System & LITe (Less Invasive Technologies) Procedural Solutions ALLENDALE, N.J.--(Healthcare Sales & Marketing Network)--Stryker’s Spine division today announced the acquisition of the Safe...
Devices, Orthopaedic, Neurosurgery, Acquisitions
Stryker, SafeWire, Y-Wire, Tiger Jamshidi Needle

St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy

Mon, 04/11/2016 - 14:43
Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. ...
Devices, Neurology, Product Launch
St. Jude Medical, dorsal root ganglion, Axium , Neurostimulator, DRG therapy

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO(TM)

Mon, 04/11/2016 - 14:35
TORONTO, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- Profound Medical Corp. (“Profound” or “Company”) (PRN.V), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the compa...
Devices, Urology, Regulatory
Profound Medical, TULSA-PRO, prostate, ablation

GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex

Mon, 04/11/2016 - 14:27
LONDON, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary ca...
Biopharmaceuticals, Neurology
GW Pharmaceuticals, Epidiolex, cannabidiol, Tuberous Sclerosis Complex

FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer

Mon, 04/11/2016 - 12:49
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Applicat...
Biopharmaceuticals, Personalized Medicine, Oncology, FDA
Genentech, Roche Group, atezolizumab, NSCLC, Cancer Immunotherapy

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong